This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Stephen Poor
Introduction
Stephen Poor is an inventor based in Cambridge, MA (US). He is currently associated with Novartis AG, a leading global healthcare company. Although he has not yet been granted any patents, his work focuses on innovative solutions in the field of ocular treatments.
Latest Patent Applications
Stephen Poor's notable patent application is titled "Compositions and Methods for Long Acting Molecules." This invention relates to compositions and methods that utilize a peptide tag that binds to hemagglutinin (HA). The HA tag can be linked to a molecule such as a protein or nucleic acid, which, when administered to the eye, results in an increase in ocular half-life and/or mean residence time, and a decrease in ocular clearance of the protein or nucleic acid. The invention also encompasses methods for treating ocular diseases, including retinal vascular disease, by administering a protein or nucleic acid linked to an HA peptide tag.
Conclusion
Stephen Poor is making strides in the field of ocular treatments through his innovative research and patent applications. His work has the potential to significantly impact the way ocular diseases are treated in the future.